C57BL/6J-Trp73em1Fcau/Orl

Status

Under development - register interest

EMMA IDEM:17006
Citation informationRRID:IMSR_EM:17006 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

 
International strain nameC57BL/6J-Trp73em1Fcau/Orl
Alternative nameTrp73tm1Fcau (TAp73flox, Trp73floxE2-3)
Strain typeEndonuclease-mediated
Allele/Transgene symbolTrp73em1Fcau
Gene/Transgene symbolTrp73

Information from provider

ProviderFrédéric CAUSERET
Provider affiliationImagine Institute, Inserm
Genetic informationLoxP sites were inserted upstream of exon 2 and downstream of exon 3, which are specific to the transcriptionally active isoforms of p73 (TAp73). Cre-mediated recombination results in the complete loss of TAp73 immunoreactivity. CRISPR/Cas9 details: The line was generated by electroporation of CRISPR/Cas9 ribonucleoprotein (RNP) complexes into C57BL/6J mouse zygotes. Cas9 protein, sgRNA, and the ssODN repair template were purchased from Integrated DNA Technologies (IDT).
Phenotypic informationHomozygous:
Homozygous floxed (loxP/loxP) mice are viable and fertile. The viability, fertility and behavior of homozygous knockout (KO) mice following Cre-mediated recombination have not yet been assessed.

Heterozygous:
Heterozygous lox/+ mice are viable and fertile. Following Cre-mediated recombination, heterozygous animals are viable and fertile, with no obvious phenotype detected.
Breeding historyThe strain was generated by electroporation of CRISPR/Cas9 ribonucleoprotein (RNP) complexes into C57BL/6J mouse zygotes. Founder animals were validated by PCR and backcrossed to C57BL/6J mice.
ReferencesNone available
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivinghomozygous C57BL/6J males

Disease and phenotype information

IMPC phenotypes (gene matching)
  • preweaning lethality, incomplete penetrance / IMPC
  • increased eosinophil cell number / IMPC
  • thrombocytosis / IMPC
  • decreased spleen weight / IMPC
  • increased blood urea nitrogen level / IMPC
MGI phenotypes (gene matching)
  • absent Cajal-Retzius cell / MGI
  • domed cranium / MGI
  • gastrointestinal hemorrhage / MGI
  • absent enterocytes / MGI
  • excessive digestive secretion / MGI
  • abnormal cerebral cortex morphology / MGI
  • abnormal cortical marginal zone morphology / MGI
  • abnormal hippocampus morphology / MGI
  • abnormal hippocampus development / MGI
  • abnormal dentate gyrus morphology / MGI
  • abnormal choroid plexus morphology / MGI
  • dilated lateral ventricles / MGI
  • abnormal hypothalamus morphology / MGI
  • abnormal trigeminal ganglion morphology / MGI
  • decreased body size / MGI
  • submission towards male mice / MGI
  • reduced male mating frequency / MGI
  • abnormal embryo development / MGI
  • periorbital edema / MGI
  • increased susceptibility to otitis media / MGI
  • conjunctivitis / MGI
  • rhinitis / MGI
  • sinus inflammation / MGI
  • hydroencephaly / MGI
  • non-obstructive hydrocephaly / MGI
  • abnormal cerebrospinal fluid production / MGI
  • intracranial hemorrhage / MGI
  • intraventricular hemorrhage / MGI
  • reduced fertility / MGI
  • male infertility / MGI
  • female infertility / MGI
  • abnormal ovulation / MGI
  • neoplasm / MGI
  • increased cellular sensitivity to gamma-irradiation / MGI
  • increased malignant tumor incidence / MGI
  • increased tumor incidence / MGI
  • increased T cell derived lymphoma incidence / MGI
  • increased lung adenocarcinoma incidence / MGI
  • increased carcinoma incidence / MGI
  • increased lung adenoma incidence / MGI
  • premature death / MGI
  • neurodegeneration / MGI
  • abnormal vomeronasal organ morphology / MGI
  • increased susceptibility to bacterial infection / MGI
  • chronic inflammation / MGI
  • abnormal hippocampal mossy fiber morphology / MGI
  • abnormal cell cycle / MGI
  • increased neuron apoptosis / MGI
  • abnormal forebrain development / MGI
  • increased hemangiosarcoma incidence / MGI
  • maternal effect / MGI
  • abnormal chromosome number / MGI
  • polyploidy / MGI
  • increased incidence of tumors by chemical induction / MGI
  • cachexia / MGI
  • abnormal female meiosis / MGI
  • decreased oocyte number / MGI
  • decreased Cajal-Retzius cell number / MGI
  • abnormal dendrite morphology / MGI
  • abnormal hippocampus CA3 region morphology / MGI
  • anovulation / MGI
  • abnormal ovarian follicle number / MGI
  • increased physiological sensitivity to xenobiotic / MGI
  • increased sensitivity to induced cell death / MGI
  • decreased neuron number / MGI
  • distended ileum / MGI
  • increased thymocyte apoptosis / MGI
  • abnormal meiotic spindle morphology / MGI
  • abnormal hippocampus neuron morphology / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • prenatal lethality, incomplete penetrance / MGI
  • increased lymphoma incidence / MGI

Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).